Research Analysts’ updated eps estimates for Tuesday, September 23rd: Aardvark Therapeutics (NASDAQ:AARD) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $40.00 price target on the stock. Actuate Therapeutics (NASDAQ:ACTU) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $20.00 price target on the [...]
Research Analysts’ Updated EPS Estimates for September 23rd (AARD, ACTU, ADVM, AIG, AIOT, AMG, ANIK, ANP, ARE, ASUR)
